Cero Therapeutics (NASDAQ: CERO) holder Isaiah Tibbs reports 8.67% stake
Rhea-AI Filing Summary
CERO THERAPEUTICS HOLDINGS, INC. reports that Isaiah Tibbs beneficially owns 1,830,007 shares of Common Stock, representing 8.67% of the class. The filing states Tibbs has sole power to vote and sole dispositive power over all 1,830,007 shares.
Positive
- None.
Negative
- None.
Insights
Beneficial owner now holds a significant minority stake with sole voting control.
The filing identifies 1,830,007 shares and 8.67% ownership with sole voting and dispositive power. This level creates a visible holder with unilateral voting control over those shares, which could matter for proxy dynamics.
Stake implications depend on future disclosures of related agreements or additional filings; subsequent filings would clarify intent or coordination with other holders.
Schedule 13G disclosure documents passive beneficial ownership above the 5% threshold.
The report lists the holder, address, class (Common Stock), and CUSIP 15687V102. The filing format signals disclosure of beneficial ownership consistent with Section 13 rules rather than an active solicitation.
Regulatory follow-up would occur if ownership crosses other thresholds or the holder changes status; no such changes are disclosed here.
FAQ
What does the Schedule 13G filed for CERO reveal about Isaiah Tibbs' holdings?
Does the filing show whether Tibbs shares voting power with others for CERO?
Is the Tibbs position in CERO a majority or minority stake?
What class and CUSIP are associated with the disclosed CERO shares?
Who signed the ownership disclosure for CERO and how is control described?